BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 28655549)

  • 1. Lower extremity bypass for critical limb ischemia decreases major adverse limb events with equivalent cardiac risk compared with endovascular intervention.
    Mehaffey JH; Hawkins RB; Fashandi A; Cherry KJ; Kern JA; Kron IL; Upchurch GR; Robinson WP
    J Vasc Surg; 2017 Oct; 66(4):1109-1116.e1. PubMed ID: 28655549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Utilization and Outcomes of Redo Lower Extremity Bypass versus Endovascular Intervention after a Previous Failed Bypass.
    Mehaffey JH; Shannon A; Hawkins RB; Fashandi A; Tracci MC; Kron IL; Upchurch GR; Robinson WP
    Ann Vasc Surg; 2018 Feb; 47():18-23. PubMed ID: 28890062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major adverse limb events and major adverse cardiac events after contemporary lower extremity bypass and infrainguinal endovascular intervention in patients with claudication.
    Fashandi AZ; Mehaffey JH; Hawkins RB; Kron IL; Upchurch GR; Robinson WP
    J Vasc Surg; 2018 Dec; 68(6):1817-1823. PubMed ID: 30470369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower extremity bypass and endovascular intervention for critical limb ischemia fail to meet Society for Vascular Surgery's objective performance goals for limb-related outcomes in a contemporary national cohort.
    Robinson WP; Mehaffey JH; Hawkins RB; Tracci MC; Cherry KJ; Eslami M; Upchurch GR
    J Vasc Surg; 2018 Nov; 68(5):1438-1445. PubMed ID: 29937289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of Outcomes After Lower Extremity Bypass and Repeat Endovascular Intervention Following Failed Previous Endovascular Intervention for Critical Limb Ischemia.
    Shannon AH; Mehaffey JH; Cullen JM; Upchurch GR; Robinson WP
    Angiology; 2019 Jul; 70(6):501-505. PubMed ID: 30376723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of open and endovascular lower extremity revascularization in active smokers with advanced peripheral arterial disease.
    Chen SL; Whealon MD; Kabutey NK; Kuo IJ; Sgroi MD; Fujitani RM
    J Vasc Surg; 2017 Jun; 65(6):1680-1689. PubMed ID: 28527930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative conduit for infrageniculate bypass in patients with critical limb ischemia.
    Moreira CC; Leung AD; Farber A; Rybin D; Doros G; Siracuse JJ; Kalish J; Eslami MH
    J Vasc Surg; 2016 Jul; 64(1):131-139.e1. PubMed ID: 27345506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of open and endovascular treatment of patients with critical limb ischemia in the Vascular Quality Initiative.
    Siracuse JJ; Menard MT; Eslami MH; Kalish JA; Robinson WP; Eberhardt RT; Hamburg NM; Farber A;
    J Vasc Surg; 2016 Apr; 63(4):958-65.e1. PubMed ID: 26830690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary Endovascular 30-Day Outcomes for Critical Limb Threatening Ischemia Relative to Surgical Bypass Grafting.
    Latz CA; Boitano L; Wang LJ; Pendleton AA; DeCarlo C; Sumpio B; Schwartz S; Srivastava S; Dua A
    Vasc Endovascular Surg; 2021 Jul; 55(5):441-447. PubMed ID: 33602047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unplanned readmissions after endovascular intervention or surgical bypass for critical limb ischemia.
    Latz CA; Wang LJ; Boitano L; DeCarlo C; Pendleton AA; Sumpio B; Schwartz S; Dua A
    J Vasc Surg; 2021 Mar; 73(3):942-949.e1. PubMed ID: 32861862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine use of completion imaging after infrainguinal bypass is not associated with higher bypass graft patency.
    Tan TW; Rybin D; Kalish JA; Doros G; Hamburg N; Schanzer A; Cronenwett JL; Farber A;
    J Vasc Surg; 2014 Sep; 60(3):678-85.e2. PubMed ID: 24721174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative beta blockade is associated with increased rates of 30-day major adverse cardiac events in critical limb ischemia patients undergoing infrainguinal revascularization.
    Shannon AH; Mehaffey JH; Cullen JM; Hawkins RB; Roy R; Upchurch GR; Robinson WP
    J Vasc Surg; 2019 Apr; 69(4):1167-1172.e1. PubMed ID: 30598355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease.
    Dayama A; Tsilimparis N; Kolakowski S; Matolo NM; Humphries MD
    J Vasc Surg; 2019 Jan; 69(1):156-163.e1. PubMed ID: 30579443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes does not worsen outcomes following infrageniculate bypass or endovascular intervention for patients with critical limb ischemia.
    Hicks CW; Najafian A; Farber A; Menard MT; Malas MB; Black JH; Abularrage CJ
    J Vasc Surg; 2016 Dec; 64(6):1667-1674.e1. PubMed ID: 27871493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoalbuminemia Predicts Perioperative Morbidity and Mortality after Infrainguinal Lower Extremity Bypass for Critical Limb Ischemia.
    Peacock MR; Farber A; Eslami MH; Kalish JA; Rybin D; Doros G; Shah NK; Siracuse JJ
    Ann Vasc Surg; 2017 May; 41():169-175.e4. PubMed ID: 28242402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after Open Lower Extremity Revascularization in Patients with Critical Limb Ischemia.
    Khoury MK; Rectenwald JE; Tsai S; Kirkwood ML; Ramanan B; Timaran CH; Modrall JG
    Ann Vasc Surg; 2020 Aug; 67():417-424. PubMed ID: 32339678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgeon, not institution, case volume is associated with limb outcomes after lower extremity bypass for critical limb ischemia in the Vascular Quality Initiative.
    Johnston LE; Tracci MC; Kern JA; Cherry KJ; Kron IL; Upchurch GR; Robinson WP
    J Vasc Surg; 2017 Nov; 66(5):1457-1463. PubMed ID: 28559173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Readmission rates after lower extremity bypass vary significantly by surgical indication.
    Jones CE; Richman JS; Chu DI; Gullick AA; Pearce BJ; Morris MS
    J Vasc Surg; 2016 Aug; 64(2):458-464. PubMed ID: 27139788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-hospital versus postdischarge major adverse events within 30 days following lower extremity revascularization.
    Liang P; Li C; O'Donnell TFX; Lo RC; Soden PA; Swerdlow NJ; Schermerhorn ML
    J Vasc Surg; 2019 Feb; 69(2):482-489. PubMed ID: 30301689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of major amputation despite patent bypass grafts.
    Smith AD; Hawkins AT; Schaumeier MJ; de Vos MS; Conte MS; Nguyen LL
    J Vasc Surg; 2016 May; 63(5):1279-88. PubMed ID: 26860641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.